Literature DB >> 29793241

Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank.

Catherine A McCarty, Russell A Wilke, Philip F Giampietro, Steve D Wesbrook, Michael D Caldwell1.   

Abstract

OBJECTIVES: The objective of this paper is to summarize the planning for Phase I of the Marshfield Clinic Personalized Medicine Research Project (PMRP) and to describe the recruitment efforts in the first 2 years.
METHODS: The purpose of Phase I of the PMRP was to develop a large population-based biobank with DNA, plasma and serum samples to facilitate genomics research. Planning and consultation was facilitated with three external boards: the Ethics and Security Advisory Board; the Scientific Advisory Board; and the Community Advisory Group. Commencing in September 2002, residents aged 18 and above who resided in 1 of 19 zip codes surrounding Marshfield, WI, USA, were invited to participate. After providing written informed consent, participants completed brief questionnaires that included questions about demographics, some environmental exposures, family history of disease, and adverse drug reactions, as well as family members living in the study area. Participants provided 50 ml of blood from which DNA was extracted and plasma and serum samples were stored. The informed consent document allowed access to electronic medical records and included language about non-disclosure of personal research results. A tick-off box was also included so that participants could either allow or decline subsequent recontact for future research studies.
RESULTS: A total of 17,463 subjects were enrolled during the first 23 months of recruitment (44.3% of the residents who the Research Project Assistants were able to contact). The participants ranged in age from 18 to 98.5 years (mean = 48.9, median = 48); 57.2% (n = 9986) were female. Self-reported race in the study cohort was similar to the year 2000 census for Wood County, WI, USA, with the majority (98%) reporting themselves to be White Caucasian. The majority of subjects (n = 13,391, 76.7%) indicated that they had German ancestry. Only 142 participants (< 1%) opted out on the consent form for contact for future studies. The majority of the cohort reported that their current area of residence was a suburb, city or village (n = 10630, 60.87%); the remainder reported residence in a rural home or hobby farm (n = 5365, 30.72%), or a working farm or ranch (n = 1451, 8.31%). More than half the cohort (n = 9409, 53.88%) had lived on a working farm at some point in their life.
CONCLUSION: The PMRP database will allow research in three areas: genetic epidemiology, pharmacogenetics, and population genetics. The size and the stability of the population as well as the relative ethnic homogeneity will help facilitate longitudinal studies with valid research results that are not biased by population stratification.

Entities:  

Keywords:  database; ethics; genetic epidemiology; longitudinal study; pharmacogenetics; pharmacogenomics; planning methodology; population genetics

Year:  2005        PMID: 29793241     DOI: 10.1517/17410541.2.1.49

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  40 in total

1.  Ethical and practical challenges of sharing data from genome-wide association studies: the eMERGE Consortium experience.

Authors:  Amy L McGuire; Melissa Basford; Lynn G Dressler; Stephanie M Fullerton; Barbara A Koenig; Rongling Li; Cathy A McCarty; Erin Ramos; Maureen E Smith; Carol P Somkin; Carol Waudby; Wendy A Wolf; Ellen Wright Clayton
Journal:  Genome Res       Date:  2011-06-01       Impact factor: 9.043

2.  Application of clinical text data for phenome-wide association studies (PheWASs).

Authors:  Scott J Hebbring; Majid Rastegar-Mojarad; Zhan Ye; John Mayer; Crystal Jacobson; Simon Lin
Journal:  Bioinformatics       Date:  2015-02-04       Impact factor: 6.937

3.  Improving breast cancer risk prediction by using demographic risk factors, abnormality features on mammograms and genetic variants.

Authors:  Shara I Feld; Kaitlin M Woo; Roxana Alexandridis; Yirong Wu; Jie Liu; Peggy Peissig; Adedayo A Onitilo; Jennifer Cox; C David Page; Elizabeth S Burnside
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

4.  Genome-Wide Association and Functional Studies Reveal Novel Pharmacological Mechanisms for Allopurinol.

Authors:  Deanna J Brackman; Sook Wah Yee; Osatohanmwen J Enogieru; Christian Shaffer; Dilrini Ranatunga; Joshua C Denny; Wei-Qi Wei; Yoichiro Kamatani; Michiaki Kubo; Dan M Roden; Eric Jorgenson; Kathleen M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2019-05-23       Impact factor: 6.875

5.  Genetic ancestry inference using support vector machines, and the active emergence of a unique American population.

Authors:  Ryan J Haasl; Catherine A McCarty; Bret A Payseur
Journal:  Eur J Hum Genet       Date:  2012-12-05       Impact factor: 4.246

6.  RNA-Binding Protein IGF2BP1 in Cutaneous Squamous Cell Carcinoma.

Authors:  TaeWon Kim; Thomas Havighurst; KyungMann Kim; Scott J Hebbring; Zhan Ye; Juliet Aylward; Sunduz Keles; Yaohui G Xu; Vladimir S Spiegelman
Journal:  J Invest Dermatol       Date:  2016-11-14       Impact factor: 8.551

7.  Applying family analyses to electronic health records to facilitate genetic research.

Authors:  Xiayuan Huang; Robert C Elston; Guilherme J Rosa; John Mayer; Zhan Ye; Terrie Kitchner; Murray H Brilliant; David Page; Scott J Hebbring
Journal:  Bioinformatics       Date:  2018-02-15       Impact factor: 6.937

8.  A gene-based recessive diplotype exome scan discovers FGF6, a novel hepcidin-regulating iron-metabolism gene.

Authors:  Shicheng Guo; Shuai Jiang; Narendranath Epperla; Yanyun Ma; Mehdi Maadooliat; Zhan Ye; Brent Olson; Minghua Wang; Terrie Kitchner; Jeffrey Joyce; Peng An; Fudi Wang; Robert Strenn; Joseph J Mazza; Jennifer K Meece; Wenyu Wu; Li Jin; Judith A Smith; Jiucun Wang; Steven J Schrodi
Journal:  Blood       Date:  2019-02-27       Impact factor: 22.113

9.  Structure-Leveraged Methods in Breast Cancer Risk Prediction.

Authors:  Jun Fan; Yirong Wu; Ming Yuan; David Page; Jie Liu; Irene M Ong; Peggy Peissig; Elizabeth Burnside
Journal:  J Mach Learn Res       Date:  2016-12       Impact factor: 3.654

10.  Validation of a metabolite panel for early diagnosis of type 2 diabetes.

Authors:  Tonia C Carter; Dietrich Rein; Inken Padberg; Erik Peter; Ulrike Rennefahrt; Donna E David; Valerie McManus; Elisha Stefanski; Silke Martin; Philipp Schatz; Steven J Schrodi
Journal:  Metabolism       Date:  2016-06-26       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.